RNAi Technology Market Size, Share, Offering (Product and Services), Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis B and C, and Others), Delivery Method (Soaking, Nanoparticles, Viral Vectors, and Others), Application (Drug Discovery & Development, Functional Genomics, and Others), End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs & CMOs, and Others), and Region - Trends, Analysis, and Forecast till 2035

RNAi technology market size was valued at USD 3.3 Billion in 2025 and is expected to reach USD 11.5 Billion by 2035 growing at a CAGR of 14.7%.

The RNAi technology market is growing due to increasing prevalence of genetic disorders, increased demand for therapies, rising demand for therapies targeting cancer, growing focus on neurological disorders, rising use of RNA interference in viral and infectious disease treatments, advancements in delivery technologies, and increased research and development.